Independent report

SaBTO virology subcommittee recommendations on KSHV infection

Recommendations to introduce universal serological screening of deceased donors for Kaposi's sarcoma-associated herpesvirus (KSHV) infection.

Documents

SaBTO virology subcommittee recommendations on KSHV: full report

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Several cases of fatal Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus type-8 (HHV-8), infection have been observed in recent years in recipients of solid organ transplants in the UK.

The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) established a workstream to look at the current scientific evidence and assess the size and impact of donor related HHV-8 infection on recipient outcomes, particularly in the setting of deceased organ donation. The working group also assessed the need and feasibility of implementing appropriate interventions.

Updates to this page

Published 31 May 2023
Last updated 13 March 2025
  1. Page updated to add the full report.

  2. First published.

Sign up for emails or print this page